This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yabe, T. Articles by Kinoshita, M. Search for Related Content PubMed PubMed Citation Articles by Yabe, T. Articles by Kinoshita, M.

Circulation, Vol 89, 1709-1716, Copyright © 1994 by American Heart Association

ARTICLES

Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise

T Yabe, K Mitsunami, M Okada, S Morikawa, T Inubushi and M Kinoshita
First Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.

BACKGROUND: The metabolic changes of myocardial ischemia in patients with coronary artery disease assessed by 31P magnetic resonance spectroscopy (MRS) have been reported previously. A significant decrease in the ratio of phosphocreatine (PCr) to ATP during handgrip exercise in a group of patients with severe coronary artery disease has been demonstrated. However, there are no reports at present that directly compare cardiac 31P MRS data with exercise 201Tl myocardial scintigraphy, now established as one of the most important clinical methods to assess myocardial ischemia. The purpose of this study was to investigate whether 31P MRS with handgrip exercise testing is able to detect myocardial ischemia, demonstrated by exercise 201Tl scintigraphy. METHODS AND RESULTS: Twenty-seven patients with severe stenosis of the left anterior descending coronary artery (> or = 75%) and 11 normal control subjects composed the present study. Patients were divided into two groups on the basis of exercise 201Tl scintigraphy: a reversible 201Tl defect group (RD[+]) who demonstrated redistribution at the late image and a fixed 201Tl defect group (RD[- ]). While lying supine within the magnet, subjects performed handgrip exercise at 30% of maximal force once in every two cardiac cycles. 31P MR spectra were collected before and during handgrip exercise. Data were corrected for the saturation factor. ANOVA revealed significant differences among the three groups with respect to the mean +/- SD PCr/ATP ratio at rest (control, 1.85 +/- 0.28 > RD(+), 1.60 +/- 0.19 > RD(-), 1.24 +/- 0.30; P < .05). The PCr/ATP ratio decreased significantly from 1.60 +/- 0.19 at rest to 0.96 +/- 0.28 during exercise (P < .001) in the RD(+) group (n = 15). However, in the RD(-) group (n = 12), the ratio did not change significantly during handgrip exercise (1.24 +/- 0.30 at rest versus 1.19 +/- 0.28 during exercise). Similarly, the ratio did not change in the control group (n = 11) (1.85 +/- 0.28 at rest versus 1.90 +/- 0.23 during exercise). CONCLUSIONS: Contrary to normal subjects or patients with fixed thallium defects, the PCr/ATP ratio was significantly altered by exercise in patients with reversible thallium defects. These results suggest that 31P MRS with handgrip exercise testing is a sensitive method for detecting myocardial ischemia.

This article has been cited by other articles:

				P. A. Bottomley, K. C. Wu, G. Gerstenblith, S. P. Schulman, A. Steinberg, and R. G. Weiss Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study Circulation, April 14, 2009; 119(14): 1918 - 1924. [Abstract] [Full Text] [PDF]

				D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF]

				M. Beer, T. Seyfarth, J.o. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1267 - 1274. [Abstract] [Full Text] [PDF]

				H. P. Beyerbacht, H. J. Lamb, A. van der Laarse, H. W. Vliegen, F. Leujes, M. G. Hazekamp, A. de Roos, and E. E. van der Wall Aortic Valve Replacement in Patients with Aortic Valve Stenosis Improves Myocardial Metabolism and Diastolic Function Radiology, June 1, 2001; 219(3): 637 - 643. [Abstract] [Full Text] [PDF]

				P. A. Bottomley and R. G. Weiss Noninvasive Localized MR Quantification of Creatine Kinase Metabolites in Normal and Infarcted Canine Myocardium Radiology, May 1, 2001; 219(2): 411 - 418. [Abstract] [Full Text]

				V. P. Chacko, F. Aresta, S. M. Chacko, and R. G. Weiss MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2218 - H2224. [Abstract] [Full Text] [PDF]

				S. D. Buchthal, J. A. den Hollander, C. N. B. Merz, W. J. Rogers, C. J. Pepine, N. Reichek, B. L. Sharaf, S. Reis, S. F. Kelsey, and G. M. Pohost Abnormal Myocardial Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy in Women with Chest Pain but Normal Coronary Angiograms N. Engl. J. Med., March 23, 2000; 342(12): 829 - 835. [Abstract] [Full Text] [PDF]

				W.-I. Jung, L. Sieverding, J. Breuer, T. Hoess, S. Widmaier, O. Schmidt, M. Bunse, F. van Erckelens, J. Apitz, O. Lutz, et al. 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy Circulation, June 30, 1998; 97(25): 2536 - 2542. [Abstract] [Full Text] [PDF]

				M. A. Conway, P. A. Bottomley, R. Ouwerkerk, G. K. Radda, and B. Rajagopalan Mitral Regurgitation : Impaired Systolic Function, Eccentric Hypertrophy, and Increased Severity Are Linked to Lower Phosphocreatine/ATP Ratios in Humans Circulation, May 5, 1998; 97(17): 1716 - 1723. [Abstract] [Full Text] [PDF]

				H. J. Lamb, H. P. Beyerbacht, R. Ouwerkerk, J. Doornbos, B. M. Pluim, E. E. van der Wall, A. van der Laarse, and A. de Roos Metabolic Response of Normal Human Myocardium to High-Dose Atropine-Dobutamine Stress Studied by 31P-MRS Circulation, November 4, 1997; 96(9): 2969 - 2977. [Abstract] [Full Text]

				E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke Magnetic Resonance Imaging in Coronary Artery Disease Circulation, November 1, 1995; 92(9): 2723 - 2739. [Abstract] [Full Text]

				G. M. Pohost Is 31P-NMR Spectroscopic Imaging a Viable Approach to Assess Myocardial Viability? Circulation, July 1, 1995; 92(1): 9 - 10. [Full Text]

				T. Yabe, K. Mitsunami, T. Inubushi, and M. Kinoshita Quantitative Measurements of Cardiac Phosphorus Metabolites in Coronary Artery Disease by 31P Magnetic Resonance Spectroscopy Circulation, July 1, 1995; 92(1): 15 - 23. [Abstract] [Full Text]